ARTICLE | Clinical News
Gepirone ER regulatory update
September 21, 2015 7:00 AM UTC
FDA’s Psychopharmacologic Drugs Advisory Committee will meet on Dec. 1 to discuss an NDA for gepirone ER from Fabre-Kramer to treat major depressive disorder (MDD). In 2007, the agency issued a not ap...